2,6-Difluoronitrobenzene | CAS:19064-24-5

We serve 2,6-Difluoronitrobenzene CAS:19064-24-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,6-Difluoronitrobenzene

Chemical Name:2,6-Difluoronitrobenzene
CAS.NO:19064-24-5
Synonyms:2,6-Difluoronitrobenzene
1,3-Difluoro-2-nitrobenzene
2,6-difluoro-1-nitrobenzene
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 220.1±20.0 °C at 760 mmHg
Molecular Formula C6H3F2NO2
Molecular Weight 159.090
Flash Point 94.1±10.1 °C
Vapour Pressure 0.2±0.4 mmHg at 25°C
Index of Refraction 1.510
 
Specification:
Appearance:Yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 2,6-Difluoronitrobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-difluoro-1-nitrobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6-difluoro-1-nitrobenzene Use and application,1,3-Difluoro-2-nitrobenzene technical grade,usp/ep/jp grade.


Related News: The South Korean government is banning entry to all foreign nationals who visited China’s Hubei province in the past 14 days.4-Chloro-7-methoxy-2-phenylquinoline manufacturer The South Korean government is banning entry to all foreign nationals who visited China’s Hubei province in the past 14 days.4-Fluoro-2-nitroanisole supplier “Out of an abundance of caution and based on the latest advice from leading health experts, we’re closing all our corporate offices, stores and contact centers in mainland China through February 9.”3-Bromo-5-fluoropicolinonitrile vendor “Out of an abundance of caution and based on the latest advice from leading health experts, we’re closing all our corporate offices, stores and contact centers in mainland China through February 9.”GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”